NovaBay Pharmaceuticals (NBY) Short Interest Ratio & Short Volume $0.71 -0.02 (-2.92%) As of 01/21/2025 04:10 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest NovaBay Pharmaceuticals Short Interest DataNovaBay Pharmaceuticals (NBY) has a short interest of 62,900 shares. This marks a 63.80% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 631,247 shares to cover all short positions.Current Short Interest62,900 sharesPrevious Short Interest38,400 sharesChange Vs. Previous Month+63.80%Dollar Volume Sold Short$0.00Short Interest Ratio0.1 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares4,210,000 sharesPercentage of Shares Shorted1.49%Today's Trading Volume184,665 sharesAverage Trading Volume631,247 sharesToday's Volume Vs. Average29% Short Selling NovaBay Pharmaceuticals? Sign up to receive the latest short interest report for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNBY Short Interest Over TimeNBY Days to Cover Over TimeNBY Percentage of Float Shorted Over Time NovaBay Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/202462,900 shares $0.00 +63.8%N/A0.1 $0.00 12/15/202438,400 shares $0.00 -47.5%N/A0.1 $0.00 11/30/202473,200 shares $0.00 -60.9%N/A0 $0.00 11/15/2024187,000 shares $0.00 -75.5%N/A0.1 $0.00 10/31/2024764,300 shares $0.00 +4,169.8%N/A0.3 $0.00 10/15/202417,900 shares $0.00 -96.0%N/A0 $0.00 9/30/2024451,700 shares $0.00 +256.5%N/A0.2 $0.00 9/15/2024126,700 shares $0.00 -6.8%N/A0 $0.00 8/31/2024135,900 shares $0.00 -29.3%N/A0.5 $0.00 8/15/2024192,200 shares $0.00 +495.1%N/A0.6 $0.00 Get the Latest News and Ratings for NBY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/202432,300 shares $0.00 -66.0%N/A0.1 $0.00 7/15/202494,900 shares $0.00 +27.0%N/A0.3 $0.00 6/30/202474,700 shares $0.00 +54.0%N/A0.2 $0.00 6/15/202448,500 shares $0.00 -92.5%N/A0.2 $0.00 5/31/2024647,600 shares $0.00 +2,023.3%84.7%2.3 $0.00 5/15/202430,500 shares $0.00 -77.7%0.1%0 $0.00 4/30/2024137,000 shares $0.00 -34.2%0.4%0.1 $0.00 4/15/2024208,100 shares $0.00 -71.1%0.6%0.1 $0.00 3/31/2024718,800 shares $0.00 +519.1%2.5%0.2 $0.00 3/15/2024116,100 shares $0.00 -57.3%0.4%0 $0.00 2/29/2024271,700 shares $0.00 -10.2%4.3%0.1 $0.00 2/15/2024302,400 shares $0.00 -47.6%4.8%0.1 $0.00 1/31/2024576,600 shares $0.00 +33.4%9.1%0.2 $0.00 1/15/2024432,400 shares $0.00 +1,226.4%6.8%0.6 $0.00 12/31/202332,600 shares $0.00 +136.2%0.5%0.1 $0.00 12/15/202313,800 shares $0.00 -58.7%0.2%0.1 $0.00 11/30/202333,400 shares $0.00 -40.8%0.5%0 $0.00 11/15/202356,400 shares $0.00 -39.1%0.9%0.1 $0.00 10/31/202392,600 shares $0.00 +21.5%2.3%0.1 $0.00 10/15/202376,200 shares $0.00 No Change1.9%0.1 $0.00 9/30/202376,200 shares $0.00 -73.0%1.9%0.1 $0.00 9/15/2023281,700 shares $0.00 +54.6%6.9%0.2 $0.00 8/31/2023182,200 shares $0.00 +0.9%4.5%0.2 $0.00 8/15/2023180,600 shares $0.00 +10.9%4.5%0.8 $0.00 7/31/2023162,900 shares $114,078.87 -43.4%4.0%0.3 $0.70 7/15/2023287,600 shares $0.00 -6.0%7.1%0.5 $0.00 6/30/2023305,900 shares $230,097.98 +9.8%7.6%0.6 $0.75 6/15/2023278,600 shares $186,076.94 +22.1%7.0%0.5 $0.67 5/31/2023228,100 shares $148,242.19 +53.6%9.1%0.5 $0.65 5/15/2023148,500 shares $0.00 -6.1%6.3%0.4 $0.00Stunning Trump Manhattan Project Now Underway (Ad)Just as I predicted, President Trump announced his #1 move during his first 100 days... His allies are calling it Trump’s Manhattan Project.You simply have to see this.. 4/30/2023158,100 shares $0.00 +81.7%8.3%1.7 $0.00 4/15/202387,000 shares $156,600.00 -2.9%5.0%1 $1.80 3/31/202389,600 shares $0.00 +3.9%5.2%3.3 $0.00 3/15/202386,200 shares $0.00 -10.2%5.0%1.9 $0.00 2/28/202396,000 shares $0.00 -3.1%5.5%1.9 $0.00 2/15/202399,100 shares $0.00 +0.1%5.7%1.7 $0.00 1/31/202399,000 shares $245,173.50 +3.0%5.7%1.4 $2.48 1/15/202396,100 shares $0.00 +115.5%5.6%1.4 $0.00 12/30/202244,600 shares $86,970.00 +8.0%2.8%0.6 $1.95 12/15/202241,300 shares $0.00 +7.8%N/A0.7 $0.00 11/30/202238,300 shares $0.00 +2.7%N/A0.6 $0.00 11/15/202237,300 shares $0.00 -96.6%N/A0.7 $0.00 10/31/20221,100,000 shares $0.00 -19.7%N/A0.8 $0.00 10/15/20221,370,000 shares $0.00 +88.0%N/A1 $0.00 9/30/2022728,800 shares $0.00 -17.4%N/A0.7 $0.00 9/15/2022881,900 shares $0.00 -48.1%N/A1.1 $0.00 8/31/20221,700,000 shares $0.00 -5.6%N/A2.8 $0.00 8/15/20221,800,000 shares $0.00 +30.4%N/A2.5 $0.00 7/31/20221,380,000 shares $0.00 +11.3%26.8%1.8 $0.00 7/15/20221,240,000 shares $0.00 -1.6%24.1%2 $0.00 6/30/20221,260,000 shares $0.00 -9.4%24.5%2 $0.00 6/15/20221,390,000 shares $0.00 +7.8%27.0%2.3 $0.00 5/31/20221,290,000 shares $0.00 +41.6%N/A2.2 $0.00 5/15/2022910,800 shares $0.00 -1.5%N/A2.1 $0.00 4/30/2022924,900 shares $0.00 +11.6%2.2%2.3 $0.00 4/15/2022828,800 shares $0.00 -9.8%2.0%2.1 $0.00 3/31/2022918,800 shares $272,240.44 -10.8%2.2%2.1 $0.30 3/15/20221,030,000 shares $0.00 +15.7%2.6%1.7 $0.00 2/28/2022890,200 shares $0.00 -7.1%2.3%1.3 $0.00 2/15/2022957,800 shares $0.00 -14.5%2.5%1.2 $0.00 1/31/20221,120,000 shares $0.00 -22.2%3.2%1.3 $0.00 1/15/20221,440,000 shares $0.00 -13.3%4.1%1.5 $0.00 12/31/20211,660,000 shares $0.00 -20.2%4.7%1.8 $0.00 12/15/20212,080,000 shares $0.00 -10.3%5.9%2.1 $0.00 11/30/20212,320,000 shares $0.00 +19.6%6.5%2.3 $0.00 11/15/20211,940,000 shares $0.00 +22.0%5.4%2.3 $0.00 10/29/20211,590,000 shares $842,700.00 -25.7%N/A1.8 $0.53 10/15/20212,140,000 shares $0.00 +5.9%6.0%1.3 $0.00 9/30/20212,020,000 shares $0.00 +4.7%5.7%1 $0.00 9/15/20211,930,000 shares $0.00 -6.8%5.4%1.1 $0.00 8/31/20212,070,000 shares $0.00 -5.1%5.9%1 $0.00 8/13/20212,180,000 shares $0.00 +29.8%6.2%1 $0.00 7/30/20211,680,000 shares $0.00 +44.8%5.2%0.8 $0.00 7/15/20211,160,000 shares $0.00 +8.4%3.6%1 $0.00 6/30/20211,070,000 shares $0.00 +29.3%3.3%1.3 $0.00 6/15/2021827,400 shares $0.00 -20.4%2.5%0.8 $0.00 5/28/20211,040,000 shares $0.00 +2.0%3.2%0.9 $0.00 5/14/20211,020,000 shares $0.00 -8.9%N/A0.6 $0.00 4/30/20211,120,000 shares $0.00 -9.7%N/A0.3 $0.00 4/15/20211,240,000 shares $954,800.00 +6.9%N/A0.3 $0.77Did You See Trump’s Manhattan Project Bombshell? (Ad)This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House. Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)... Trump’s first Executive Order would easily be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years. Click here and see for yourself. 3/31/20211,160,000 shares $928,000.00 +13.7%N/A0.2 $0.80 3/15/20211,020,000 shares $856,800.00 +53.1%N/A0.2 $0.84 2/26/2021666,400 shares $673,064.00 -22.6%N/A0.1 $1.01 2/12/2021861,400 shares $783,874.00 -22.4%N/A0.2 $0.91 1/29/20211,110,000 shares $1.38 million +6.7%N/A0.4 $1.24 1/15/20211,040,000 shares $1.25 million +2.0%N/A0.4 $1.20 12/31/20201,020,000 shares $740,418.00 -22.7%N/A0.6 $0.73 12/15/20201,320,000 shares $918,588.00 +10.0%N/A0.9 $0.70 11/30/20201,200,000 shares $762,000.00 +26.3%N/A0.9 $0.64 11/15/2020950,500 shares $577,333.70 -1.8%N/A0.8 $0.61 10/30/2020968,000 shares $599,869.60 +18.0%N/A0.4 $0.62 10/15/2020820,100 shares $627,376.50 +106.3%N/A0.3 $0.77 9/30/2020397,500 shares $290,175.00 -22.8%N/A0.1 $0.73 9/15/2020515,100 shares $370,872.00 +0.8%N/A0.1 $0.72 8/31/2020511,200 shares $388,512.00 -6.4%N/A0.1 $0.76 8/14/2020546,200 shares $475,194.00 +12.0%N/A0.1 $0.87 7/31/2020487,900 shares $473,263.00 -60.7%N/A0.1 $0.97 7/15/20201,240,000 shares $1.53 million +267.4%N/A0.2 $1.23 6/30/2020337,500 shares $401,625.00 +35.5%1.7%0.1 $1.19 6/15/2020249,000 shares $288,840.00 +49.4%1.3%0.1 $1.16 5/29/2020166,700 shares $208,375.00 -55.8%1.0%0 $1.25 5/15/2020376,700 shares $320,195.00 +16.2%2.3%0.1 $0.85 4/30/2020324,300 shares $288,627.00 -20.5%1.9%0.1 $0.89 4/15/2020407,800 shares $411,878.00 +14.2%2.5%0.1 $1.01 3/31/2020357,000 shares $321,300.00 +150.0%2.2%0.2 $0.90 3/13/2020142,800 shares $107,100.00 +44.4%0.9%0.6 $0.75 2/28/202098,900 shares $89,999.00 -34.7%0.6%0.4 $0.91 2/14/2020151,400 shares $68,130.00 -53.5%0.9%0.5 $0.45 1/31/2020325,700 shares $192,163.00 -20.6%2.0%0.6 $0.59 NBY Short Interest - Frequently Asked Questions What is NovaBay Pharmaceuticals' current short interest? Short interest is the volume of NovaBay Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 62,900 shares of NBY short. Learn More on NovaBay Pharmaceuticals' current short interest. Is NovaBay Pharmaceuticals' short interest increasing or decreasing? NovaBay Pharmaceuticals saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 62,900 shares, an increase of 63.8% from the previous total of 38,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does NovaBay Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to NovaBay Pharmaceuticals: CervoMed Inc. (23.55%), Relmada Therapeutics, Inc. (5.47%), TherapeuticsMD, Inc. (0.11%), Acurx Pharmaceuticals, Inc. (2.76%), Apollomics, Inc. (1.59%), Cellectar Biosciences, Inc. (4.70%), Inhibitor Therapeutics, Inc. (0.01%), Brainstorm Cell Therapeutics Inc. (2.11%), Turnstone Biologics Corp. (3.24%), BioLineRx Ltd. (1.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short NovaBay Pharmaceuticals stock? Short selling NBY is an investing strategy that aims to generate trading profit from NovaBay Pharmaceuticals as its price is falling. NBY shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NovaBay Pharmaceuticals? A short squeeze for NovaBay Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NBY, which in turn drives the price of the stock up even further. How often is NovaBay Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NBY, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies CRVO Short Interest Data RLMD Short Interest Data TXMD Short Interest Data ACXP Short Interest Data APLM Short Interest Data CLRB Short Interest Data INTI Short Interest Data BCLI Short Interest Data TSBX Short Interest Data BLRX Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEAMERICAN:NBY) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTexas embraces new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovaBay Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NovaBay Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NBY Stock Alerts